-
1
-
-
0033841239
-
Alendronate in the treatment of osteoporosis: A Review of the clinical trials
-
DOI 10.1089/15246090050118125
-
Siris E. Alendronate in the treatment of osteoporosis: a review of the clinical trials. J Womens Health Gender-Based Med. 2000;9:599-606. (Pubitemid 30654898)
-
(2000)
Journal of Women's Health and Gender-Based Medicine
, vol.9
, Issue.6
, pp. 599-606
-
-
Siris, E.1
-
2
-
-
0032583492
-
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial
-
Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280:2077-2082.
-
(1998)
JAMA
, vol.280
, pp. 2077-2082
-
-
Cummings, S.R.1
Black, D.M.2
Thompson, D.E.3
-
3
-
-
0032896590
-
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study
-
DOI 10.1007/PL00004171
-
Pols HAP, Felsenberg D, Hanley DA, et al. Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results from the FOSIT study. Osteoporosis Int. 1999;9:461-468. (Pubitemid 29231740)
-
(1999)
Osteoporosis International
, vol.9
, Issue.5
, pp. 461-468
-
-
Pols, H.A.P.1
Felsenberg, D.2
Hanley, D.A.3
Stepan, J.4
Munoz-Torres, M.5
Wilkin, T.J.6
Qin-Sheng, G.7
Galich, A.M.8
Vandormael, K.9
Yates, A.J.10
Stych, B.11
-
4
-
-
22844452550
-
Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women
-
Papapoulos SE, Quandt SA, Liberman UA, Hochberg MC, Thompson DE. Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women. Osteoporosis Int. 2005;16: 468-474.
-
(2005)
Osteoporosis Int
, vol.16
, pp. 468-474
-
-
Papapoulos, S.E.1
Quandt, S.A.2
Liberman, U.A.3
Hochberg, M.C.4
Thompson, D.E.5
-
5
-
-
0028851590
-
Effect of oral alendronate on the bone mineral density and the incidence of fractures in postmenopausal osteoporosis
-
Liberman UA, Weiss SR, Bröll J, et al. Effect of oral alendronate on the bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med. 1995;333:1437-1443.
-
(1995)
N Engl J Med
, vol.333
, pp. 1437-1443
-
-
Liberman, U.A.1
Weiss, S.R.2
Bröll, J.3
-
7
-
-
21644458377
-
Bone fragility and collagen cross-links
-
Paschalis EP, Shane E, Lyritis G, Skarantavos G, Mendelsohn R, Boskey AL. Bone fragility and collagen cross-links. J Bone Miner Res. 2004;19: 2000-2004.
-
(2004)
J Bone Miner Res
, vol.19
, pp. 2000-2004
-
-
Paschalis, E.P.1
Shane, E.2
Lyritis, G.3
Skarantavos, G.4
Mendelsohn, R.5
Boskey, A.L.6
-
8
-
-
0034906270
-
Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women
-
DOI 10.1016/S8756-3282(01)00485-9, PII S8756328201004859
-
Roschger P, Rinnerthaler S, Yates J, Rodan GA, Fratzl P, Klaushofer K. Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone. 2001;29:185-191. (Pubitemid 32737191)
-
(2001)
Bone
, vol.29
, Issue.2
, pp. 185-191
-
-
Roschger, P.1
Rinnerthaler, S.2
Yates, J.3
Rodan, G.A.4
Fratzl, P.5
Klaushofer, K.6
-
9
-
-
5344266050
-
Bone mineralization density and femoral neck fragility
-
DOI 10.1016/j.bone.2004.05.025, PII S8756328204002212
-
Loveridge N, Power J, Reeve J, Boyde A. Bone mineralization density and femoral neck fragility. Bone. 2004;35:929-941. (Pubitemid 39349224)
-
(2004)
Bone
, vol.35
, Issue.4
, pp. 929-941
-
-
Loveridge, N.1
Power, J.2
Reeve, J.3
Boyde, A.4
-
10
-
-
33745485305
-
Effects of 3- And 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women
-
DOI 10.1359/jbmr.060401
-
Zoehrer R, Roschger P, Fratzl P, et al. Effects of 3- and 5-year treatment with risedronate on the bone mineral density distribution of cancellous bone in human iliac crest biopsies. J Bone Miner Res. 2006;21:1106-1112. (Pubitemid 43962839)
-
(2006)
Journal of Bone and Mineral Research
, vol.21
, Issue.7
, pp. 1106-1112
-
-
Zoehrer, R.1
Roschger, P.2
Paschalis, E.P.3
Hofstaetter, J.G.4
Durchschlag, E.5
Fratzl, P.6
Phipps, R.7
Klaushofer, K.8
-
11
-
-
32844454532
-
Age-related change in the damage morphology of human cortical bone and its role in bone fragility
-
DOI 10.1016/j.bone.2005.09.002, PII S8756328205003789
-
Diab T, Condon KW, Burr DB, Vashishth D. Age-related change in the damage morphology of human cortical bone and its role in bone fragility. Bone. 2006;38:427-431. (Pubitemid 43255437)
-
(2006)
Bone
, vol.38
, Issue.3
, pp. 427-431
-
-
Diab, T.1
Condon, K.W.2
Burr, D.B.3
Vashishth, D.4
-
12
-
-
4043114822
-
Structure and mechanical quality of the collagen-mineral nano-composite in bone
-
Fratzl P, Gupta HS, Paschalis EP, Roschger P. Structure and mechanical quality of the collagen-mineral nano-composite in bone. J Mater Chem. 2004;14:2115-2123.
-
(2004)
J Mater Chem
, vol.14
, pp. 2115-2123
-
-
Fratzl, P.1
Gupta, H.S.2
Paschalis, E.P.3
Roschger, P.4
-
13
-
-
0033755981
-
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women
-
Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 2000; 27:687-694.
-
(2000)
Bone
, vol.27
, pp. 687-694
-
-
Boivin, G.Y.1
Chavassieux, P.M.2
Santora, A.C.3
Yates, J.4
Meunier, P.J.5
-
15
-
-
33744932166
-
Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: Sequential triple biopsy studies with micro-computed tomography
-
DOI 10.1016/j.bone.2006.01.161, PII S875632820600202X
-
Borah B, Dufresne TE, Ritman EL, et al. Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography. Bone. 2006;39:345-352. (Pubitemid 43851366)
-
(2006)
Bone
, vol.39
, Issue.2
, pp. 345-352
-
-
Borah, B.1
Dufresne, T.E.2
Ritman, E.L.3
Jorgensen, S.M.4
Liu, S.5
Chmielewski, P.A.6
Phipps, R.J.7
Zhou, X.8
Sibonga, J.D.9
Turner, R.T.10
-
17
-
-
49149128059
-
The role of mineralization and organic matrix in the microhardness of bone tissue from controls and osteoporotic patients
-
Boivin G, Bala Y, Doublier A, et al. The role of mineralization and organic matrix in the microhardness of bone tissue from controls and osteoporotic patients. Bone. 2008;43:532-538.
-
(2008)
Bone
, vol.43
, pp. 532-538
-
-
Boivin, G.1
Bala, Y.2
Doublier, A.3
-
18
-
-
0035992618
-
Synchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: Effects of etidronate treatment
-
Nuzzo S, Lafage-Proust MH, Martin-Badosa E, et al. Synchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: effect of etidronate treatment. J Bone Miner Res. 2002;17:1372-1382. (Pubitemid 34803821)
-
(2002)
Journal of Bone and Mineral Research
, vol.17
, Issue.8
, pp. 1372-1382
-
-
Nuzzo, S.1
Lafage-Proust, M.H.2
Martin-Badosa, E.3
Boivin, G.4
Thomas, T.5
Alexandre, C.6
Peyrin, F.7
-
19
-
-
39149107458
-
Bone mineralization density distribution in health and disease
-
Roschger P, Paschalis EP, Fratzl P, Klaushofer K. Bone mineralization density distribution in health and disease. Bone. 2008;42:456-466.
-
(2008)
Bone
, vol.42
, pp. 456-466
-
-
Roschger, P.1
Paschalis, E.P.2
Fratzl, P.3
Klaushofer, K.4
-
21
-
-
34147181146
-
The bone mineralization density distribution as a fingerprint of the mineralization process
-
DOI 10.1016/j.bone.2007.01.012, PII S8756328207000373
-
Ruffoni D, Fratzl P, Roschger P, Klaushofer K, Weinkamer R. The bone mineralization density distribution as a fingerprint of the mineralization process. Bone. 2007;40:1308-1319. (Pubitemid 46566431)
-
(2007)
Bone
, vol.40
, Issue.5
, pp. 1308-1319
-
-
Ruffoni, D.1
Fratzl, P.2
Roschger, P.3
Klaushofer, K.4
Weinkamer, R.5
-
22
-
-
0037343826
-
Constant mineralization density distribution in cancellous human bone
-
DOI 10.1016/S8756-3282(02)00973-0
-
Roschger P, Gupta HS, Berzlanovich A, et al. Constant mineralization density distribution in cancellous human bone. Bone. 2003;32:316-323. (Pubitemid 36349536)
-
(2003)
Bone
, vol.32
, Issue.3
, pp. 316-323
-
-
Roschger, P.1
Gupta, H.S.2
Berzlanovich, A.3
Ittner, G.4
Dempster, D.W.5
Fratzl, P.6
Cosman, F.7
Parisien, M.8
Lindsay, R.9
Nieves, J.W.10
Klaushofer, K.11
-
23
-
-
77953453638
-
Long-term treatment with oral bisphosphonates in postmenopausal women: Effects on the degree of mineralization and microhardness of bone
-
abstract 1029
-
Boivin G, Bala Y, Chapurlat RD, Delmas PD. Long-term treatment with oral bisphosphonates in postmenopausal women: effects on the degree of mineralization and microhardness of bone [abstract 1029]. ASBMR 30th Annual Meeting, Montreal, Canada, September 12-16, 2008.
-
ASBMR 30th Annual Meeting, Montreal, Canada, September 12-16, 2008
-
-
Boivin, G.1
Bala, Y.2
Chapurlat, R.D.3
Delmas, P.D.4
-
24
-
-
33845890326
-
Effects of continuing or stopping alendronate after 5 years of treatment: The fracture intervention trial long-term extension (FLEX) - A randomized trial
-
Black DM, Schwartz AV, Ensrud KE, et al. Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX) - a randomized trial. JAMA. 2006;296:2927-2938.
-
(2006)
JAMA
, vol.296
, pp. 2927-2938
-
-
Black, D.M.1
Schwartz, A.V.2
Ensrud, K.E.3
-
25
-
-
12144289279
-
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
-
DOI 10.1056/NEJMoa030897
-
Bone HG, Hosking D, Devogelaer JP, et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med. 2004;350:1189-1199. (Pubitemid 38339363)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.12
, pp. 1189-1199
-
-
Bone, H.G.1
Hosking, D.2
Devogelaer, J.-P.3
Tucci, J.R.4
Emkey, R.D.5
Tonino, R.P.6
Rodriguez-Portales, J.A.7
Downs, R.W.8
Gupta, J.9
Santora, A.C.10
Liberman, U.A.11
-
26
-
-
14644399915
-
Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: Results from the fracture intervention trial long-term extension
-
DOI 10.1359/JBMR.040326
-
Ensrud KE, Barrett-Connor EL, Schwartz A, et al. Randomized trial of effects of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial Long-Term Extension. J Bone Miner Res. 2004;19:1259-1269. (Pubitemid 41094366)
-
(2004)
Journal of Bone and Mineral Research
, vol.19
, Issue.8
, pp. 1259-1269
-
-
Ensrud, K.E.1
Barrett-Connor, E.L.2
Schwartz, A.3
Santora, A.C.4
Bauer, D.C.5
Suryawanshi, S.6
Feldstein, A.7
Haskell, W.L.8
Hochberg, M.C.9
Torner, J.C.10
Lombardi, A.11
Black, D.M.12
-
27
-
-
2942724382
-
A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage
-
Nyman JS, Yeh OC, Hazelwood SJ, Martin RB. A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage. Bone. 2004;35:296-305.
-
(2004)
Bone
, vol.35
, pp. 296-305
-
-
Nyman, J.S.1
Yeh, O.C.2
Hazelwood, S.J.3
Martin, R.B.4
-
28
-
-
0037370624
-
Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra
-
DOI 10.1359/jbmr.2003.18.3.512
-
Komatsubara S, Mori S, Mashiba T, et al. Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra. J Bone Miner Res. 2003;18:512-520. (Pubitemid 36241068)
-
(2003)
Journal of Bone and Mineral Research
, vol.18
, Issue.3
, pp. 512-520
-
-
Komatsubara, S.1
Mori, S.2
Mashiba, T.3
Ito, M.4
Li, J.5
Kaji, Y.6
Akiyama, T.7
Miyamoto, K.8
Cao, Y.9
Kawanishi, J.10
Norimatsu, H.11
-
29
-
-
38449101476
-
Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment
-
Allen MR, Burr DB. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment. J Bone Miner Res. 2007;22:1759-1765.
-
(2007)
J Bone Miner Res
, vol.22
, pp. 1759-1765
-
-
Allen, M.R.1
Burr, D.B.2
-
30
-
-
34547568211
-
Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis
-
Stepan JJ, Burr DB, Pavo I, et al. Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone. 2007;41:378-385.
-
(2007)
Bone
, vol.41
, pp. 378-385
-
-
Stepan, J.J.1
Burr, D.B.2
Pavo, I.3
-
31
-
-
36549086149
-
Microcrack frequency and bone remodeling in postmenopausal osteoporotic women in longterm bisphosphonates a bone biopsy study
-
Chapurlat RD, Arlot M, Burt-Pichat B, et al. Microcrack frequency and bone remodeling in postmenopausal osteoporotic women in longterm bisphosphonates: a bone biopsy study. J Bone Miner Res. 2007;22:1502-1509.
-
(2007)
J Bone Miner Res
, vol.22
, pp. 1502-1509
-
-
Chapurlat, R.D.1
Arlot, M.2
Burt-Pichat, B.3
-
32
-
-
0030868816
-
Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis
-
Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest. 1997;100:1475-1480.
-
(1997)
J Clin Invest
, vol.100
, pp. 1475-1480
-
-
Chavassieux, P.M.1
Arlot, M.E.2
Reda, C.3
Wei, L.4
Yates, A.J.5
Meunier, P.J.6
-
33
-
-
0037341841
-
Characteristics of mineral particles in the human bone/cartilage interface
-
Zizak I, Roschger P, Paris O, et al. Characteristics of mineral particles in the human bone/cartilage interface. J Struct Biol. 2003;141:208-217.
-
(2003)
J Struct Biol
, vol.141
, pp. 208-217
-
-
Zizak, I.1
Roschger, P.2
Paris, O.3
-
34
-
-
17644445505
-
Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies
-
Roschger P, Fratzl P, Eschberger J, Klaushofer K. Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone. 1998; 23:319-26.
-
(1998)
Bone
, vol.23
, pp. 319-326
-
-
Roschger, P.1
Fratzl, P.2
Eschberger, J.3
Klaushofer, K.4
-
35
-
-
0032922097
-
Scanning small angle X-ray scattering analysis of human bone sections
-
Rinnerthaler S, Roschger P, Jakob HF, Nader A, Klaushofer K, Fratzl P. Scanning small angle X-ray scattering analysis of human bone sections. Calcif Tissue Int. 1999;64:422-429.
-
(1999)
Calcif Tissue Int
, vol.64
, pp. 422-429
-
-
Rinnerthaler, S.1
Roschger, P.2
Jakob, H.F.3
Nader, A.4
Klaushofer, K.5
Fratzl, P.6
-
36
-
-
0028882234
-
A new scanning electron microscopy approach to the quantification of bone mineral distribution: Backscattered electron image grey-levels correlated to calcium K alpha-line intensities
-
discussion 86-88
-
Roschger P, Plenk H Jr, Klaushofer K, Eschberger J. A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K alpha-line intensities. Scanning Microsc. 1995;9:75-86; discussion 86-88.
-
(1995)
Scanning Microsc
, vol.9
, pp. 75-86
-
-
Roschger, P.1
Plenk Jr., H.2
Klaushofer, K.3
Eschberger, J.4
-
37
-
-
0030435844
-
Bone mineralization as studied by small-angle x-ray scattering
-
Fratzl P, Schreiber S, Klaushofer K. Bone mineralization as studied by small-angle x-ray scattering. Connect Tissue Res. 1996;34:247-254. (Pubitemid 27126611)
-
(1996)
Connective Tissue Research
, vol.34
, Issue.4
, pp. 247-254
-
-
Fratzl, P.1
Schreiber, S.2
Klaushofer, K.3
-
38
-
-
0026732689
-
The prevention and treatment of osteoporosis
-
Riggs BL, Melton LJ III. The prevention and treatment of osteoporosis. N Engl J Med. 1992;327:620-627.
-
(1992)
N Engl J Med
, vol.327
, pp. 620-627
-
-
Riggs, B.L.1
Iii, M.L.J.2
-
39
-
-
56749095466
-
Effect of temporal changes in bone turnover on the bone mineralization density distribution: A computer simulation study
-
Ruffoni D, Fratzl P, Roschger P, Phipps R, Klaushofer K, Weinkamer R. Effect of temporal changes in bone turnover on the bone mineralization density distribution: a computer simulation study. J Bone Miner Res. 2008;23:1905-1914.
-
(2008)
J Bone Miner Res
, vol.23
, pp. 1905-1914
-
-
Ruffoni, D.1
Fratzl, P.2
Roschger, P.3
Phipps, R.4
Klaushofer, K.5
Weinkamer, R.6
-
40
-
-
34547753938
-
Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume
-
Fratzl P, Roschger P, Fratzl-Zelman N, Paschalis EP, Phipps R, Klaushofer K. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume. Calcif Tissue Int. 2007;81:73-80.
-
(2007)
Calcif Tissue Int
, vol.81
, pp. 73-80
-
-
Fratzl, P.1
Roschger, P.2
Fratzl-Zelman, N.3
Paschalis, E.P.4
Phipps, R.5
Klaushofer, K.6
-
41
-
-
0023743121
-
Trabecular architecture in iliac crest bone biopsies: Infra-individual variability in structural parameters and changes with age
-
Parisien MV, McMahon D, Pushparaj N, Dempster DW. Trabecular architecture in iliac crest bone biopsies: infra-individual variability in structural parameters and changes with age. Bone. 1988;9:289-295.
-
(1988)
Bone
, vol.9
, pp. 289-295
-
-
Parisien, M.V.1
McMahon, D.2
Pushparaj, N.3
Dempster, D.W.4
-
42
-
-
33749259617
-
Bone material properties in trabecular bone from human iliac crest biopsies after 3- And 5-year treatment with risedronate
-
Durchschlag E, Paschalis E, Zöhrer R, et al. Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate. J Bone Miner Res. 2006;21: 1581-1590.
-
(2006)
J Bone Miner Res
, vol.21
, pp. 1581-1590
-
-
Durchschlag, E.1
Paschalis, E.2
Zöhrer, R.3
-
43
-
-
15944413442
-
Severely suppressed bone turnover: A potential complication of alendronate therapy
-
Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CYC. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90:1294-1301.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 1294-1301
-
-
Odvina, C.V.1
Zerwekh, J.E.2
Rao, D.S.3
Maalouf, N.4
Gottschalk, F.A.5
Pak, C.Y.C.6
-
44
-
-
37549071454
-
Positive effects of intravenous zoledronic acid on bone remodeling and structure: Are different effects on osteoblast activity to other oral bisphosphonates responsible?
-
Ebeling PR, Burr DB. Positive effects of intravenous zoledronic acid on bone remodeling and structure: are different effects on osteoblast activity to other oral bisphosphonates responsible? J Bone Miner Res. 2008;23:2-5.
-
(2008)
J Bone Miner Res
, vol.23
, pp. 2-5
-
-
Ebeling, P.R.1
Burr, D.B.2
-
45
-
-
23044499935
-
Microcracks colocalize within highly mineralized regions of cortical bone tissue
-
Wasserman N, Yerramshetty J, Akkus O. Microcracks colocalize within highly mineralized regions of cortical bone tissue. Eur J Morphol. 2005;42:43-51.
-
(2005)
Eur J Morphol
, vol.42
, pp. 43-51
-
-
Wasserman, N.1
Yerramshetty, J.2
Akkus, O.3
-
46
-
-
37549039804
-
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure
-
Recker RR, Delmas PD, Halse J, et al. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res. 2008;23:6-16.
-
(2008)
J Bone Miner Res
, vol.23
, pp. 6-16
-
-
Recker, R.R.1
Delmas, P.D.2
Halse, J.3
|